Brief: Sonoma Pharmaceuticals Says Board Appointed CEO To Serve As A Member Of Board
July 22 (Reuters) - Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS INC - EFFECTIVE JULY 22, 2022,
BOARD
APPOINTED AMY TROMBLY, CEO, TO SERVE AS A MEMBER OF BOARD OF
DIRECTORS
Source: (https://bit.ly/3OrTDBY)
Further company coverage: SNOA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing